Cargando…
Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
Aberrant sialylation plays a key biological role in tumorigenesis and metastasis, including tumor cell survival and invasion, immune evasion, angiogenesis, and resistance to therapy. It has been proposed as a possible cancer biomarker and a potential therapeutic target of tumors. Nevertheless, the p...
Autores principales: | Zhou, Mingxuan, Lv, Silin, Hou, Yufang, Zhang, Rixin, Wang, Weiqi, Yan, Zheng, Li, Tiegang, Gan, Wenqiang, Zeng, Zifan, Zhang, Fang, Yang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623420/ https://www.ncbi.nlm.nih.gov/pubmed/36330513 http://dx.doi.org/10.3389/fimmu.2022.994874 |
Ejemplares similares
-
Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer
por: Hou, Yufang, et al.
Publicado: (2022) -
Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023) -
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
por: Zhang, Fang, et al.
Publicado: (2023) -
SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021) -
High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)